Candel Therapeutics (CADL) Change in Account Payables (2020 - 2023)
Historic Change in Account Payables for Candel Therapeutics (CADL) over the last 4 years, with Q4 2023 value amounting to $172000.0.
- Candel Therapeutics' Change in Account Payables rose 13161.76% to $172000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $45000.0, marking a year-over-year increase of 10370.98%. This contributed to the annual value of -$185000.0 for FY2024, which is 51111.11% down from last year.
- As of Q4 2023, Candel Therapeutics' Change in Account Payables stood at $172000.0, which was up 13161.76% from -$214000.0 recorded in Q3 2023.
- Over the past 5 years, Candel Therapeutics' Change in Account Payables peaked at $818000.0 during Q3 2020, and registered a low of -$579000.0 during Q1 2022.
- In the last 4 years, Candel Therapeutics' Change in Account Payables had a median value of $43500.0 in 2023 and averaged -$15642.9.
- As far as peak fluctuations go, Candel Therapeutics' Change in Account Payables skyrocketed by 22360.59% in 2021, and later tumbled by 43468.21% in 2022.
- Quarter analysis of 4 years shows Candel Therapeutics' Change in Account Payables stood at -$538000.0 in 2020, then skyrocketed by 223.61% to $665000.0 in 2021, then crashed by 181.8% to -$544000.0 in 2022, then skyrocketed by 131.62% to $172000.0 in 2023.
- Its Change in Account Payables was $172000.0 in Q4 2023, compared to -$214000.0 in Q3 2023 and -$62000.0 in Q2 2023.